Prognostic Impact of Late Gadolinium Enhancement on Major Adverse Cardiovascular Events and Time‐Varying Attenuation of Risk in Dilated Cardiomyopathy
Clinical Cardiology · 2026-11 · 49 (11)
DOI: 10.1002/clc.70506 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cardiology, online erschienen am 29.10.2026. Verfasst von Liyuan Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: General Hospital of Ningxia Medical University, Yinchuan, China. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Magnetic Resonance Imaging, Cine, Contrast Media, Gadolinium. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yinchuan Science and Technology Plan Project.
Abstract (Originalsprache)
Objectives
To investigate the prognostic value of late gadolinium enhancement (LGE) extent for major adverse cardiovascular events (MACE) in dilated cardiomyopathy (DCM) patients and characterize the dynamic pattern of its risk effect over time.
Methods
We retrospectively enrolled patients who underwent Cardiac Magnetic Resonance (CMR) between 2020 and 2024, with MACE (cardiac death, heart failure re‐hospitalization, or sustained ventricular arrhythmia) as the endpoint. Patients were stratified by MACE occurrence. Schoenfeld residual testing showed borderline deviation of the proportional hazards (PH) assumption for LGE extent (LV mass percentage). Thus, a time‐dependent Cox model (Extended Cox PHs Model) with an LGE extent × follow‐up time interaction term was built to assess dynamic hazard ratio changes, and independent MACE risk factors were identified.
Results
Among 173 DCM patients (age 47 ± 15 years, 105 males), 46 (26.6%) experienced MACE after a mean follow‐up of 27 ± 16 months. The time‐dependent Cox model identified LGE extent (baseline HR: 1.243, 95% CI: 1.162–1.329, p < 0.001), the LGE extent × time interaction (HR: 0.993, 95% CI: 0.989–0.997, p = 0.001), and LV end‐diastolic volume index (LVEDVi; HR = 1.008, 95% CI: 1.003–1.014, p = 0.001) as independent MACE predictors. Notably, the risk effect of LGE extent demonstrated time‐dependent attenuation.
Conclusion
LV LGE extent and LVEDVi independently predict MACE in DCM patients. The early prognostic value of LGE extent suggests a critical time window for early fibrosis intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- General Hospital of Ningxia Medical University, Yinchuan, China.
- The First Clinical Medical College of Ningxia Medical University, Yinchuan, China.
- Department of Radiology, General Hospital of Ningxia Medical University, Yinchuan, China.
Förderung
- Yinchuan Science and Technology Plan Project
Zitieren
APA
Ma, L., Li, Y., Zhang, H., Zheng, Y., Wang, P., Niu, Y., & Zhu, L. (2026). Prognostic Impact of Late Gadolinium Enhancement on Major Adverse Cardiovascular Events and Time‐Varying Attenuation of Risk in Dilated Cardiomyopathy. Clinical Cardiology, 49(11). https://doi.org/10.1002/clc.70506
Vancouver
Ma L, Li Y, Zhang H, Zheng Y, Wang P, Niu Y, et al. Prognostic Impact of Late Gadolinium Enhancement on Major Adverse Cardiovascular Events and Time‐Varying Attenuation of Risk in Dilated Cardiomyopathy. Clinical Cardiology. 2026;49(11). doi:10.1002/clc.70506
BibTeX
@article{Ma2026,
author = {Ma, Liyuan and Li, Yuan and Zhang, Huairong and Zheng, Yan and Wang, Pei and Niu, Yuanyuan and Zhu, Li},
title = {Prognostic Impact of Late Gadolinium Enhancement on Major Adverse Cardiovascular Events and Time‐Varying Attenuation of Risk in Dilated Cardiomyopathy},
journal = {Clinical Cardiology},
year = {2026},
volume = {49},
number = {11},
doi = {10.1002/clc.70506}
}
EUVIMED